http://www.biospace.comBioSpace RSS GeneratorSat, 25 May 2013 15:39:19 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><font size"3"><b>BTG PLC ACQUISITION OF EKOS</font></b><br><br>23 May 2013 -- A fast-growing and profitable interventional vascular business BTG plc (BTG or the Company), the specialist healthcare company...Thu, 23 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130523005977&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) (Elan) today announced that its Board of Directors, after careful review and consideration and with the assistance of its executive management team...Thu, 23 May 2013 12:00:00 AM GMThttp://in.reuters.com/article/2013/05/22/us-merck-bertarelli-biotech-idINBRE94L0LC20130522Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker...Wed, 22 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297334&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><font size"3"><b>Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million</font></b><br><br>OSLO & COPENHAGEN--(BUSINESS WIRE)-- Xellia Pharmaceuticals (Xellia), a pharmaceutical group focusing on...Tue, 21 May 2013 12:00:00 AM GMThttp://www.thisismoney.co.uk/money/markets/article-2326646/Pharma-giant-Shire-return-2bn-investors.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>British drugs giant Shire is looking at ways of giving as much as 2billion back to its shareholders to bolster its defences against a possible foreign takeover bid. New chief executive Flemming Ornskov has...Tue, 21 May 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-05-20/royalty-pharma-raises-elan-bid-to-12-50-a-shae-in-cash.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Royalty Pharma, an investor in royalty streams from pharmaceuticals, raised its offer to buy Elan Corp. (ELN) by 12 percent to $6.4 billion after the Irish drugmaker made acquisitions to boost revenue and resist...Tue, 21 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130521005727&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>NOKOMIS, Fla.--(BUSINESS WIRE)--As part of the companys push to carve out a share of the $142 billion U.S. drug delivery market, Rainbow Coral Corp. (OTCBB: RBCC) opened talks this week to potentially partner...Tue, 21 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130520006365&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. announced today that it has acquired Actagene Oncology, Inc., effective May 20, 2013. Actagene was a San Diego based privately held biotechnology company founded in February...Tue, 21 May 2013 12:00:00 AM GMThttp://www.washingtonpost.com/business/actavis-buying-warner-chilcott-in-all-stock-transaction-valued-at-about-85-billion/2013/05/20/37e628b0-c140-11e2-9aa6-fc21ae807a8a_story.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5 billion which would create the third-biggest specialty pharmaceutical company in the U.S. The announcement on Monday comes after...Mon, 20 May 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/05/20/us-elan-idUSBRE94J04I20130520Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Elan will still have $1.2 billion of cash left to spend if shareholders approve its first package of acquisitions, and plans to announce more deals in the second half of the year, chief executive Kelly Martin...Mon, 20 May 2013 12:00:00 AM GMThttp://uk.reuters.com/article/2013/05/16/roche-novartis-stake-idUKL6N0DP1ME20130516Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>A changing of the guard at Switzerland's two biggest drugmakers is fuelling talk that Novartis may finally sell its multi-billion-dollar stake in cross-town rival Roche, potentially unlocking value for both...Fri, 17 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297127&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">SAN JOSE, Calif.</span>, <span class"xn-chron">May 17, 2013</span> /PRNewswire-iReach/ -- Aridis is pleased to announce that an agreement has been reached...Fri, 17 May 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/05/16/us-actavis-novartis-idUSBRE94F0KH20130516Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday. "We have no intention to pursue...Thu, 16 May 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/05/16/us-steigerwald-bayer-idUSBRE94F0HF20130516Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>German pharmaceutical company Bayer AG (BAYN.XE) Thursday said it has bought privately held pharmaceutical firm Steigerwald Arzneimittelwerk GmbH in Darmstadt. MAIN FACTS: -Financial details weren't disclosed...Thu, 16 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296966&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p /><p /><p><span class"xn-location">MOUNTAIN VIEW, Calif.</span>, <span class"xn-chron">May 16, 2013</span> /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) today announced that...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515006923&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE : ELN) (Elan) today announces publication of a response document in respect of the Echo Pharma Acquisition Limited (Royalty Pharma) offer made on May 2, ...Thu, 16 May 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-05-14/actavis-said-to-have-spurned-15-billion-offer-from-mylan-1-.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Actavis Inc (ACT.N) received and rejected a takeover offer from Mylan Inc (MYL.O) last week that valued the generic drugmaker at more than $15 billion, a person familiar with the situation told Reuters on Tuesday...Wed, 15 May 2013 12:00:00 AM GMThttp://www.utsandiego.com/news/2013/may/14/optimer-gets-bidders/Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>AstraZeneca Plc (AZN) and Cubist Pharmaceuticals Inc. (CBST) are among the suitors that made first-round bids for Optimer Pharmaceuticals Inc. (OPTR), the antibiotics maker weighing a sale, said people familiar...Wed, 15 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296554&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p /><p><span class"xn-location">SAN DIEGO</span> and <span class"xn-location">IRVINE, Calif.</span>, <span class"xn-chron">May 13, 2013</span> /PRNewswire/ -- Sorrento Therapeutics...Tue, 14 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296322&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><b>Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement</b><br><br>SOUTH SAN FRANCISCO, Calif. & DUBLIN-- Theravance, Inc. (THRX) and Elan Corporation, plc (ELN) today announced...Mon, 13 May 2013 12:00:00 AM GMThttp://www.iol.co.za/business/companies/adcock-silent-on-proposal-details-1.1514492#.UZDwDsoviW8Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Pharmaceutical group Adcock Ingram is being pursued by two new suitors, in addition to Brian Joffes Bidvest. Speculation is running high that French pharmaceutical giant Sanofi is firmly in the running. Insiders...Mon, 13 May 2013 12:00:00 AM GMThttp://www.nj.com/business/index.ssf/2013/05/parsippanys_actavis_warner_chi.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Drugmakers Actavis Inc. and Warner Chilcott PLC said Friday that they in early talks about a possible combination of the two companies. Both say there is no agreement on a deal yet. Shares of both companies...Mon, 13 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296355&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><b>AmerisourceBergen Completes Divestiture of AndersonBrecon</b><br><br>SEATTLE</span> and <span class"xn-location">PHILADELPHIA</span>, <span class"xn-chron">May 13, 2013</span> /PRNewswire/ -- Frazier...Mon, 13 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130513005823&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has acquired Logos Technologies (Logos) representing...Mon, 13 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/13/546531/10032484/en/Announcement-Under-Irish-Takeover-Rules-Relevant-Securities-in-Issue.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>DUBLIN, Ireland, May 13, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "Company") confirms that, as of the close of business on May...Mon, 13 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295733&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>OSAKA, Japan</span> and DEERFIELD, Ill. and <span class"xn-location">FORT COLLINS, Colo.</span>, <span class"xn-chron">May 7, 2013</span> /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and...Thu, 09 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296104&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>LINCOLNSHIRE, Ill. & BAUDETTE, Minn.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that each company will hold a...Thu, 09 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295843&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>SYDNEY, Wednesday, 8 May 2013: Cellmid Limited (ASX: CDY) today announced that it will acquire Advangen Inc., Japan (Advangen), the Company that owns the FGF-5 inhibitor hair growth technology. Cellmid already...Wed, 08 May 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130506_1by Richard Daverman, PhD</p><p>May 6, 2013 -- Sagent Pharmaceuticals, a Chicago-area maker of generic injectable drugs, will acquire its partners 50% interest in a China JV for $25 million. Chengdu Kanghong Pharmaceuticals owned the other half of the JV, which was established in 2006 to build an FDA/GMP compliant manufacturing facility. Sagent apparently expects to use the China facility to manufacture...Tue, 07 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295355&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>SCHAUMBURG, Ill., May 6, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced an agreement...Mon, 06 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/06/544507/0/en/NeuroSearch-A-S-sells-land-and-building.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Today, NeuroSearch (NEUR) signed an agreement with PKA regarding the sale of the company's land and building effective from 1 June 2013 at a cash price of DKK 112.5 million. The agreement is final and unconditional...Mon, 06 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295489&full=1<div id"releaseBody"><p>SAN DIEGO, CA--(Marketwired - May 06, 2013) - Regen BioPharma, wholly owned subsidiary of <b>Bio-Matrix Scientific Group, Inc</b><b>. </b>(OTCQB: <a href"http://www.marketwire.com/mw/stock.jsp?TickerBMSN">BMSN</a>), announced today it has purchased patent #8,389,708 from Professor Wei-Ping Min of the University of Western Ontario, London, Canada. This patent covers...Mon, 06 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295478&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div id"releaseBody"><p>BAGSV&#230;RD, DENMARK--(Marketwired - May 03, 2013) - <p><br><br><br><br>Company announcement No 34 / 2013:<a href"http://hugin.info/2013/R/1699289/56048...Mon, 06 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295249&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>TARRYTOWN, N.Y.</span>, <span class"xn-chron">May 3, 2013</span> /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has expanded its ophthalmology portfolio by acquiring...Fri, 03 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294927&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>PARSIPPANY, N.J.</span>, and <span class"xn-location">MONTREAL</span>, <span class"xn-chron">May 1, 2013</span> /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), and Valeant Pharmaceuticals International, Inc...Wed, 01 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294967&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">BOSTON</span>, <span class"xn-chron">April 30, 2013</span> /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL), a global <a href"http://www...Wed, 01 May 2013 12:00:00 AM GMTStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>HILDEN, Germany and REDWOOD CITY, California, April 29, 2013 /PRNewswire/ --</p><p>- Ingenuity Systems is the global market leader in applications to quickly analyze and accurately interpret rapidly...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294773&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>GENEVA</span>, <span class"xn-chron">April 30, 2013</span> /PRNewswire/ -- Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130430by Richard Daverman, PhD</p><p>April 29, 2013 -- Shanghai Fosun Pharma, Chindex and a private equity partner will spend up to $240 million to buy 95.6% of an Israeli medical device company, Alma Lasers. Alma, which had revenues of about $100 million last year, makes lasers and other products, primarily for aesthetic procedures. Fosun said the investment represented a growing internationalization...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294820&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">BETHESDA, Md.</span>, <span class"xn-chron">April 29, 2013</span> /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX, "Chindex"), an American healthcare...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294843&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p /><p /><p /><p><span class"xn-location">LUND, Sweden</span>, <span class"xn-chron">April 30, 2013</span> /PRNewswire/ -- <b>On <span class"xn-chron">April 26</span><sup>th</sup...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294810&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>30 April 2013 -- Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis services business, announces the acquisition of the entire issued share capital of Inverclyde Biologicals...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294648&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>WAYNE, N.J. and <span class"xn-location">MOUNTAIN VIEW, Calif.</span>, <span class"xn-chron">April 29, 2013</span> /PRNewswire/ -- Bayer intends to broaden its portfolio in the field of contraception. Thus...Mon, 29 Apr 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/04/26/us-actavis-valeant-idUSBRE93P1CB20130426Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Canada's biggest listed drug maker, Valeant Pharmaceuticals International Inc (VRX.TO), is in talks to buy generic drugmaker Actavis Inc (ACT.N) for more than $13 billion, Wall Street Journal reported...Mon, 29 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294684&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">CHESTERBROOK, Pa.</span> and <span class"xn-location">LAKE FOREST, Ill.</span>, <span class"xn-chron">April 29, 2013</span> /PRNewswire/ -- Auxilium Pharmaceuticals...Mon, 29 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294526&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>ROCKVILLE, Md. Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an asset purchase agreement to acquire the Healthcare Protective Products Division (HPPD) of Bracco Diagnostics...Fri, 26 Apr 2013 12:00:00 AM GMThttp://www.theaustralian.com.au/news/world/glaxo-eyes-tasty-15bn-for-lucozade-ribena/story-fnb64oi6-1226629607223Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>GlaxoSmithKline confirmed yesterday that Lucozade and Ribena were on the block, with analysts predicting they could raise as much as pound stg. 1 billion ($1.5bn). "We are excited about what we have seen...Fri, 26 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294432&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p /><p /><p /><p><span class"xn-location">IRVINGTON, N.Y.</span>, <span class"xn-chron">April 24, 2013</span> /PRNewswire/ -- New Company, Abyrx, Inc. ("the Company"), today announced...Thu, 25 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294447&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">LAVAL, Quebec</span>, <span class"xn-chron">April 25, 2013</span> /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ...Thu, 25 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294408&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">LAVAL, Quebec</span>, <span class"xn-chron">April 23, 2013</span> /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced...Thu, 25 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294192&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>MIAMI and NES-ZIONA, Israel, April 24, 2013 /PRNewswire/ -- OPKO Health, Inc. (OPK) and PROLOR Biotech, Inc. (NYSE MKT: PBTH) today announced that the companies have signed a definitive merger agreement under...Wed, 24 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294257&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">LAVAL, Quebec</span>, <span class"xn-chron">April 24, 2013</span> /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX...Wed, 24 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294260&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div id"releaseBody"><p>PISCATAWAY, NJ--(Marketwired - April 23, 2013) - Enzon Pharmaceuticals, Inc. (NASDAQ: <a href"http://www.marketwire.com/mw/stock.jsp?TickerENZN">ENZN</a>) today announced...Wed, 24 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294148&full=1April 23, 2013 -- Wetzlar, Germany / Sao Paulo, Brazil. Leica Microsystems and Leica Biosystems have cemented ties with their Brazilian Leica distributor: All shares of Aotec Instrumentos Cientificos Ltda of So Paulo, Brazil, have been acquired. Aotec is a provider of microscopy and histopathology solutions and has been a Leica distributor for more than 25 years. All Aotec associates will remain with...Tue, 23 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294149&full=1SANTA BARBARA, Calif. & BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--April 23, 2013-- Miltenyi Biotec announced today that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and commercializing microchip-based cell sorting systems using fully-closed disposable cartridges in an easy-to-use format. The acquisition underscores Miltenyi's commitment to bringing comprehensive...Tue, 23 Apr 2013 12:00:00 AM GMThttp://www.irishtimes.com/business/sectors/health-pharma/elan-s-board-rejects-royalty-pharma-bid-1.1368407Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&source"news-signup"">free GenePool newsletter</a> today!<br><br>The board of directors of Elan Corp. (ELN) Monday unanimously rejected a takeover bid by Royalty Pharma, a knockback in the U.S. investment firm's two-month-old pursuit of the Irish biotechnology company...Mon, 22 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293968&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&source"news-signup"">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">MONTREAL</span>, <span class"xn-chron">April 22, 2013</span> /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced...Mon, 22 Apr 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130422Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>by Richard Daverman, PhD</p><p>April 22, 2013 -- Tasly Pharmaceutical, a company known mainly for its TCM products, paid 1.5 billion RMB ($240 million) to acquire Jiangsu TaslyDiyi Pharmaceutical, a maker...Mon, 22 Apr 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/04/22/539981/10029304/en/Innovus-Pharmaceuticals-Completes-Asset-Purchase-of-Ex-U-S-Rights-to-CIRCUMserum-TM.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>LA JOLLA, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV), today announced that it has completed the acquisition of the global...Mon, 22 Apr 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/04/19/abbott-russia-idUSL5N0D61Z820130419Russia's government commission on foreign investment has turned down U.S. group Abbott Laboratories' request to buy Russian vaccine maker Petrovax, the head of Russia's competition regulator said on Friday. "The commission has reviewed the question about the sale to U.S. company Abbott of Petrovax Pharm. As a result of very lengthy discussion the U.S. company was denied to make this deal," Igor Artemyev...Fri, 19 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293724&full=1<div class"xn-content"><p><span class"xn-location">NEW BRUNSWICK, N.J.</span>, <span class"xn-chron">April 18, 2013</span> /PRNewswire/ -- Johnson &amp; Johnson (NYSE: JNJ) today announced the sale to Elan Corporation, plc of approximately 82 million American Depositary Shares (ADS) of Elan held by Janssen Pharmaceutical (Janssen), an affiliate of Johnson &amp; Johnson. This sale took place in...Fri, 19 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293826&full=1BALTIMORE</span>, <span class"xn-chron">April 19, 2013</span> /PRNewswire/ -- Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside <span class"xn-location">the United States</span> and <span class...Fri, 19 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293686&full=1Upland, CA - April, 2013 -- Analytik Jena AG, based in Jena, Germany has acquired all of the outstanding shares of Upland, California based UVP, LLC including its subsidiary, Ultra-Violet Products, Ltd., located in Cambridge UK. </p><p> UVP is a leading manufacturer of bioimaging systems for applications in proteomics, genomics, plant and animal sciences. The company also manufactures...Thu, 18 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293690&full=1BILLERICA, Mass., April 16, 2013 Entegris, Inc. (NasdaqGS: ENTG), a leader incontamination control and materials handling solutions for very demanding manufacturingenvironments, today reported it acquired the assets of privately held Jetalon Solutions, Inc., aCalifornia-based supplier of fluid metrology products. The transaction, which was completed onApril 1, 2013, was not deemed material...Thu, 18 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293717&full=1 <div class"xn-content"><p><span class"xn-location">HOUSTON</span>, <span class"xn-chron">April 18, 2013</span> /PRNewswire/ -- The <span class"xn-org">University of Texas</span> MD Anderson Cancer Center (<span class"xn-location">Houston, Texas</span>) has purchased two Elekta Versa HD linear accelerators. The radiation therapy system, which recently received 510(k) clearance from the U.S. Food...Thu, 18 Apr 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/04/18/539380/0/en/Biohit-has-implemented-Euroclone-acquisition-new-company-will-start-as-Italian-subsidiary.htmlBiohit Oyj announces the closing of Euroclone acquisition today. The new company, Biohit Italy S.r.l., will begin operations as a Biohit subsidiary focusing on marketing and distribution of companys diagnostic products in Italy. New subsidiary has distribution network and market knowledge of Italian market.Thu, 18 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293505&full=1INDIANAPOLIS</span>, <span class"xn-chron">April 17, 2013</span> /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions <span class"xn-location">USA</span>, Inc. The tracers are intended to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks of Alzheimer...Wed, 17 Apr 2013 12:00:00 AM GMThttp://www.rttnews.com/2095637/hikma-decides-to-retain-injectables-business-stock-falls-update.aspxHikma Pharmaceuticals Plc (HIK) will keep its injectable-drug business after concluding a review of the unit, saying the long-term growth potential is excellent. The stock fell as much as 8.4 percent in London. We are confident that retaining and continuing to invest in this business is the best option for shareholders, Chief Executive Officer Said Darwazah said in a statement today. Injectables...Wed, 17 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293285&full=1 <div class"xn-content"><p><span class"xn-location">NEW YORK</span>, <span class"xn-chron">April 15, 2013</span> /PRNewswire/ -- Echo Pharma Acquisition Limited ("Royalty Pharma") today announced, pursuant to Rule 2.5 of the Irish Takeover Rules (the "Announcement"), the terms of a firm, all cash offer (the "Offer") for the entire issued and to be issued share capital of Elan Corporation, plc ...Mon, 15 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293288&full=1<div class"xn-content"><p><span class"xn-location">LIBERTY, Mo.</span>, <span class"xn-chron">April 15, 2013</span> /PRNewswire/ -- Antigen Laboratories, Inc., today announced that its parent company Planet Biopharmaceuticals, Inc. has signed a definitive agreement to be acquired by Ares Life Sciences (Ares), a healthcare focused investment group. Closing of the transaction is subject to certain...Mon, 15 Apr 2013 12:00:00 AM GMThttp://uk.reuters.com/article/2013/04/11/roche-results-chugai-idUKL5N0CY2PQ20130411Swiss drugmaker Roche has no plans to change its holding in Japan's Chugai Pharmaceutical and the recent weakening of the yen would not be a reason to trigger such a move. Asked if Roche might raise its stake in Chugai, Roche CEO Severin Schwan told analysts on Thursday: "We don't see changes in the structural set-up ... currency fluctuations would not drive such strategic M&A decisions." Chugai became...Fri, 12 Apr 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/04/12/us-elan-royalty-idUSBRE93B0J120130412Irish drugmaker Elan won strong approval from shareholders for a $1 billion share buyback as it seeks to keep them on side and stave off a takeover approach from U.S. investment firm Royalty Pharma. The buyback, priced between $11.25 and $13.00 per share, was supported by 99.2 percent of shareholders on Friday. The company was returning cash to investors after the $3.2 billion sale of its interest...Fri, 12 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293081&full=1Paris, 11 April 2013 Eyevensys, a developer of a new process for non-viral gene therapy using electrotransfer that enables prolonged production of therapeutic proteins for the treatment of ocular disease, today announces an equity investment by the Boehringer Ingelheim Venture Fund (BIVF). It also announces that Dr Michel Pairet, Boehringer Ingelheim's head of non-clinical research and development...Fri, 12 Apr 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130410_1by Richard Daverman, PhD</p><p>April 10, 2013 -- Eli Lillys animal health division, Elanco, will make a $100 million investment into China Animal Healthcare Ltd. The capital, which will give Elanco a 20% stake in China Animal Health, will be used, in part, to de-list China Animal Health from the Singapore Stock Exchange. China Animal Health IPOd in Singapore in 2007, and then instituted a secondary...Thu, 11 Apr 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130409005538&newsLang=enMORRISTOWN, N.J.--(BUSINESS WIRE)--Alitair Pharmaceuticals, Inc., an early stage pharmaceutical company with multiple respiratory product candidates in development, today announced that it has retained Finn, Warnke & Gayton, LLP (FWG), to sell two Alitair patents and an associated royalty stream at a sealed bid sale on May 24, 2013. The first patent was issued in 2012 and covers the use of ion exchange...Tue, 09 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292849&full=1Gilbertsville, PA. April 9, 2013 Rockland Immunochemicals, Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, today announced the acquisition of the Epi-Plus antibody product line from 21st Century Biochemicals, Inc.</p><p>Epi-Plus antibodies are widely regarded as the most well validated antibodies...Tue, 09 Apr 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130409_1NEWARK, Del.--(BUSINESS WIRE)--SDIX (NASDAQ: SDIX), a leading provider of biotechnology-based products and services, today announced that it has entered into an agreement to sell the assets of its Life Science business to OriGene Technologies, Inc. for $16 million. OriGene is acquiring substantially all of the assets of SDIX and has agreed to offer employment to a substantial majority of SDIXs employees...Mon, 08 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292527&full=1SAN DIEGO, April 4, 2013 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co."; TYO: 2802) and Althea Technologies, Inc. ("Althea Technologies"), have completed the previously announced acquisition of Althea Technologies, a leading provider of biopharmaceutical development and manufacturing services.</p><p>(Logo: http://photos.prnewswire.com/prnh/20121024/LA98976LOGO)</p><p>Ajinomoto acquired...Fri, 05 Apr 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/04/02/us-ache-sale-idUSBRE9310UV20130402At least three of the world's top drugmakers are bidding for Brazil's Ache Laboratorios Farmaceuticos in an auction that may value the group at more than $5 billion, people familiar with the matter said. Pfizer Inc, Novartis AG and Abbott Laboratories are all weighing second-round bids to acquire the company, which boasts a strong position in Brazil's fast-growing pharmaceuticals market, the people...Thu, 04 Apr 2013 12:00:00 AM GMTBERKELEY HEIGHTS, N.J., April 4, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced that it has entered into a definitive agreement with Celgene Corporation ("Celgene") to sell to Celgene four Cyclacel-owned patents related to the use of romidepsin injection. In connection with the agreement Celgene has made to Cyclacel a one...Thu, 04 Apr 2013 12:00:00 AM GMT